LEXINGTON, Mass., May 27, 2016 /PRNewswire/ — MẌ Orthopedics Corp. (MẌO) of Lexington, Massachusetts is proud to announce that the company has been awarded a $750,000 “Accelerator Loan” from the Massachusetts Life Sciences Center (MLSC). The Accelerator Loan – awarded on a competitive basis to promising early-stage companies in Massachusetts – will assist MẌO in the commercialization of the company’s “dynaMẌ™” line of superelastic orthopedic fracture fixation implants made from the shape memory alloy Nitinol.
“MẌ Orthopedics is extremely grateful to have been awarded the MLSC Accelerator Loan,” said Matthew Fonte, Founder and President of MẌO. “This is an exciting time for MẌO as the company moves from our engineering to our commercialization phase. The MẌO team is truly appreciative of the support that MLSC has provided to our company and, more broadly, for the incredibly positive impact the organization has on the Massachusetts life sciences cluster.”
MẌO applies sound engineering principles and sophisticated metallurgical know-how to the design of superelastic implants in order to optimize biologic healing. Deleterious implant instability and bone resorption can be minimized through calculated implant internal fixation forces generated between bone segments. The dynaMẌ™ line is engineered to generate and sustain higher levels of compression at the fracture site as the bone remodels. MẌO’s sophisticated products are Engineered to Heal™.
Accelerator Loan applications were subjected to a rigorous peer review process, followed by an evaluation by the MLSC’s Scientific Advisory Board (SAB). Applicants were then further screened by the MLSC’s Investment Sub-Committee of the Board of Directors, through a process that included a live presentation by finalists. Final awards were determined by the MLSC’s Board of Directors.
For more information, please contact:
MẌ Orthopedics, Corp.
SOURCE MX Orthopedics, Corp.